The effects of antacids on urinary pH
Tsega, E.; Tegene, N.; Tessema, D.
Ethiopian Medical Journal 14(4): 179-184
1976
ISSN/ISBN: 0014-1755 PMID: 16749 Document Number: 108656
Document emailed within 1 workday
Related Documents
Monges, H.; Hancy, A.; Rouison, D.; Chabaud, M. 1971: Comparative study of the action of antacids on the gastric pH. in situ determination by telemetry (10 antacids, 200 tests) Archives Francaises des Maladies de l'Appareil Digestif 60(8): 482Hurwitz, A.; Robinson, R.G.; Vats, T.S.; Whittier, F.C.; Herrin, W.F. 1976: Effects of antacids on gastric emptying Gastroenterology 71(2): 268-273
Tympner, F. 1985: Evidence of the cytoprotective action of antacids. Behavior of the transmural stomach electric potential difference with antacids in healthy subjects and stomach ulcer patients Fortschritte der Medizin 103(33): 795-798
Ulrichsen, H.; Jervell, J.; Dyrbekk, D.; Strømsaeter, C.E.; Størset, O. 1983: Severe adverse effects after using calcium carbonate antacids Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(30): 2052-2055
Takeuchi, H.; Okada, Y.; Yoshida, O.; Konishi, T.; Tomoyoshi, T.; Nakahara, S. 1989: Urinary tract infection associated with urinary calculi. 2. Effects of antibiotics on bacteria within infected stones Hinyokika Kiyo. Acta Urologica Japonica 35(5): 755-761
Nomiyama, K.; Liu, S.J.; Nomiyama, H. 1992: Critical levels of blood and urinary cadmium, urinary beta 2-microglobulin and retinol-binding protein for monitoring cadmium health effects Iarc Scientific Publications 118: 325-340
Minami, M.; Togashi, H.; Sano, M.; Yoshioka, M.; Saito, I.; Morii, K.; Tochihara, M.; Hirogami, M.; Nomura, A.; Saito, H. 1985: Effects of new antihypertensive agent, 2-[4-(n-butyryl)-homopiperazine-1-ul]-4-amino-6, 7-dimethoxy-quinazoline (E-643), on blood pressure, urinary sodium excretion and urinary norepinephrine excretion rate in stroke-prone, spontaneously hypertensive rats Hokkaido Journal of Medical Science 60(4): 536-543
Rana, S. 1990: Are antacids cytoprotective? Journal of the Association of Physicians of India 38(7): 521
Halter, F. 1993: Clinical use of antacids Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 44(3 Suppl 1: 61-74
Petersen, H. 1982: Antacids in non-ulcer dyspepsia Scandinavian Journal of Gastroenterology. Suppl 75: 77-78
Braverman, D.; Jacobson, W. 1976: Antacids in peptic ulcer Harefuah 90(10): 493-494
Pilbrant, A. 1982: Principles for development of antacids Scandinavian Journal of Gastroenterology. Suppl 75: 32-36
Tytgat, G.N. 1995: Reinstatement of calcium-containing antacids Nederlands Tijdschrift Voor Geneeskunde 139(47): 2405-2407
Feurle, G. 1974: Mechanism of gastrin liberation through antacids Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 515-516
Schnekenburger, J. 1981: In vitro studies on antacids/Third communication Arzneimittel-Forschung 31(8): 1286-1290
Sklar, D.; Liang, M.H.; Porta, J. 1977: Antacids: cost, taste and buffering New England Journal of Medicine 296(17): 1007
Heinkel, K. 1977: Stress--gastrin--antacids (ediorial) Münchener Medizinische Wochenschrift 119(5 Suppl): 7-8
de Paula Castro, L. 1988: Antacids and duodenal ulcer: an update Arquivos de Gastroenterologia 25 Spec No: 50-56
Mielcarek, J.; Sapór, J. 1992: Interaction between papaverine hydrochloride and antacids Acta Poloniae Pharmaceutica 49(5-6): 23-26
Vatier, J.; Vallot, T.; Vitre, M.T.; Mignon, M. 1990: New approach for the in vitro evaluation of antacids Arzneimittel-Forschung 40(2 Part 1): 175-179